Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in ACHV — Achieve Life Sciences, Inc.

CIK 19617 NEW YORK, NY
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$210,847
+$210,792 QoQ
Shares Held
32,289
+169842.1% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 111 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. ACHV ranks #232 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in ACHV

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $210,847 32,289
2026-03-31 $55 19
2025-12-31 $94 19
2025-09-30 $59 19
2025-06-30 $5,106 2,260
2025-03-31 $75,461 28,263
2024-12-31 $208,611 59,265
2024-09-30 $70,881 14,954
2024-06-30 $68,981 14,677
2023-03-31 $1,700 250